Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Adicet Bio, Inc.

< Previous 1 2 3 4 Next >
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Announces Appointment of Katie Peng to the Board of Directors
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Tickers ACET
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.